Efficacy, tolerability, and safety of xanomeline-trospium chloride for schizophrenia: A systematic review and meta-analysis.
- DOI
- 10.1016/j.euroneuro.2024.11.013
- Published
- 2025 Mar
- Container
- European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.euroneuro.2024.11.013,
title = {Efficacy, tolerability, and safety of xanomeline-trospium chloride for schizophrenia: A systematic review and meta-analysis.},
author = {Fabiano N and Wong S and Zhou C and Correll CU and Højlund M and Solmi M},
year = {2025},
journal = {European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology},
doi = {10.1016/j.euroneuro.2024.11.013},
url = {https://doi.org/10.1016/j.euroneuro.2024.11.013}
}RIS
TY - JOUR TI - Efficacy, tolerability, and safety of xanomeline-trospium chloride for schizophrenia: A systematic review and meta-analysis. AU - Fabiano N AU - Wong S AU - Zhou C AU - Correll CU AU - Højlund M AU - Solmi M PY - 2025 JO - European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology DO - 10.1016/j.euroneuro.2024.11.013 UR - https://doi.org/10.1016/j.euroneuro.2024.11.013 ER -
APA
N, F., S, W., C, Z., CU, C., M, H., & M, S. (2025). Efficacy, tolerability, and safety of xanomeline-trospium chloride for schizophrenia: A systematic review and meta-analysis.. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. https://doi.org/10.1016/j.euroneuro.2024.11.013
Source records
- pubmed · retrieved 2026-09-26T12:37:12.687Z
- europe-pmc · retrieved 2026-09-26T12:37:12.695Z